_
Itchy Business! Canine Atopic Dermatitis WebinarPLUS Itchy Business! Canine Atopic Dermatitis WebinarPLUS Is allergen immunotherapy still worth it? Canine atopic dermatitis (cAD) is everywhere, being one of the most common causes of pruritic dermatitis in the dog. Recent advances in our understanding of the disease have ushered in an exciting new era of antipruritics to manage allergy signs in dogs. We’re all using Apoquel and Cytopoint in our patients and we’re awaiting the newest JAK inhibitor in this space, Zenrelia, with much anticipation. So, what is gold standard for managing cAD in 2025 and is there still a place for desensitisation with allergen immunotherapy?

Itchy Business! Canine Atopic Dermatitis WebinarPLUS

Is allergen immunotherapy still worth it? Canine atopic dermatitis (cAD) is everywhere, being one of the most common causes of pruritic dermatitis in the dog. Recent advances in our understanding of the disease have ushered in an exciting new era of antipruritics to manage allergy signs in dogs. We’re all using Apoquel and Cytopoint in our patients and we’re awaiting the newest JAK inhibitor in this space, Zenrelia, with much anticipation. So, what is gold standard for managing cAD in 2025 and is there still a place for desensitisation with allergen immunotherapy?

_	Picture Logo
Callum Bennie BSc(Vet), BVSc, MS, DACVD, MANZCVS Board Certified Veterinary Dermatologist WebinarPLUS Duration: 1:06:31 Thursday, 18 September 2025 Topic/s:

This video content is for members or purchasers only

For information about becoming a member, please click here. For assistance with your account, please contact us. Please visit our CVeSHOP to find videos available for purchase.